Resultats globals: 4 registres trobats en 0.02 segons.
Articles, 4 registres trobats
Articles 4 registres trobats  
1.
9 p, 599.8 KB Reduced 8-Gray Compared to Standard 12-Gray Total Body Irradiation for Allogeneic Transplantation in First Remission Acute Lymphoblastic Leukemia : A Study of the Acute Leukemia Working Party of the EBMT / Spyridonidis, Alexandros (University of Patras) ; Labopin, Myriam (Sorbonne University) ; Savani, Bipin (Vanderbilt University Medical Center) ; Giebel, Sebastian (Maria Sklodowska-Curie National Research Institute of Oncology) ; Bug, Gesine (Department of Medicine II. Goethe-University) ; Schönland, Stefan (Medical Department V. University Hospital Heidelberg) ; Kröger, Nicolaus (Department of Stem Cell Transplantation. University Medical Center) ; Stelljes, Matthias (Department of Hematology/Oncology. University of Muenster) ; Schroeder, Thomas (Department of Bone Marrow Transplantation. University Hospital) ; Mcdonald, Andrew (Netcare Pretoria East Hospital) ; Blau, Igor-Wolfgang (Charité - Universitätsmedizin Berlin) ; Bornhäuser, Martin (University Hospital. TU Dresden) ; Rovira, Montse (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Bethge, Wolfgang (Department of Hematology & Oncology. University Hospital Tuebingen.) ; Neubauer, Andreas (Philipps Universitaet Marburg) ; Ganser, Arnold (Hannover Medical School) ; Bourhis, Jean Henri (Gustave Roussy Cancer Campus BMT. Department of Hematology) ; Edinger, Matthias (University Regensburg. Department of Hematology and Oncology) ; Lioure, Bruno (Hematology. Stem Cell Transplant Unit. ICANS) ; Wulf, Gerald (University Medicine Goettingen) ; Schäfer-Eckart, Kerstin (Klinikum Nuernberg. 5. Medizinische Klinik. BMT-Unit) ; Arat, Mutlu (Demiroglu Bilim Univ. Istanbul Florence Nightingale Hospital) ; Peric, Zinaida (University Hospital Centre) ; Schmid, Christoph (Universitatsklinikum Augsburg. Section Stem Cell Transplantation. Augsburg University and Medical Faculty) ; Bazarbachi, Ali (Bone Marrow Transplantation Program. Department of Internal Medicine. American University of Beirut-Medical Center) ; Ciceri, Fabio (Ospedale San Raffaele) ; Nagler, Arnon (Hematology Division. Chaim Sheba Medical Center) ; Mohty, Mohamad (Sorbonne Université)
In this registry-based study, we compared outcomes of allogeneic hematopoietic cell transplantation (allo-HCT) in adult patients with acute lymphoblastic leukemia (ALL) transplanted in first complete remission (CR-1), following conditioning with total body irradiation (TBI) at a standard 12-Gray or at a lower 8-Gray total dose. [...]
2023 - 10.1097/HS9.0000000000000812
HemaSphere, Vol. 7 Núm. 1 (september 2023) , p. e812  
2.
12 p, 804.5 KB RIC versus MAC UCBT in adults with AML : A report from Eurocord, the ALWP and the CTIWP of the EBMT / Baron, Frédéric (University of Liege) ; Ruggeri, Annalisa (Hôpital Saint-Antoine (Paris, França)) ; Beohou, Eric (Hôpital Saint-Antoine (Paris, França)) ; Labopin, Myriam (Hôpital Saint-Antoine (Paris, França)) ; Sanz, Guillermo (Hospital Universitari i Politècnic La Fe (València)) ; Milpied, Noel (University of Bordeaux) ; Michallet, Mauricette (Centre Hospitalier de Lyon Sud) ; Bacigalupo, Andrea (Ospedale San Martino) ; Blaise, Didier (Aix-Marseille Université) ; Malouf Sierra, Jorge 1971- (Institut d'Investigació Biomèdica Sant Pau) ; Socié, Gérard (Hospital Saint-Louis) ; Cornelissen, Jan J. (Erasmus Medical Center-Daniel den Hoed Cancer Center) ; Schmid, Christoph (University of Munich) ; Giebel, Sebastian (Gliwice Branch) ; Gorin, Norbert-Claude (Hospital Saint Antoine) ; Esteve, Jordi (Hematology. Hospital Clinic) ; Ciceri, Fabio (Ospedale San Raffaele) ; Savani, Bipin N. (Vanderbilt University Medical Center) ; Mohty, Mohamad (UMRs 938) ; Gluckman, Eliane (Centre Scientifique de Monaco) ; Nagler, Arnon (The Chaim Sheba Medical Center) ; Universitat Autònoma de Barcelona
Nonrelapse mortality (NRM) is the first cause of treatment failure after unrelated cord blood transplantation (UCBT) following myeloablative conditioning (MAC). In the last decade, reduced-intensity conditioning (RIC) regimens have been developed with the aim of reducing NRM and allowing older patients and those with medical comorbidities to benefit from UCBT. [...]
2016 - 10.18632/oncotarget.9599
Oncotarget, Vol. 7 Núm. 28 (2016) , p. 43027-43038  
3.
13 p, 2.7 MB Minimal residual disease level predicts outcome in adults with Ph-negative Bprecursor acute lymphoblastic leukemia / Gökbuget, Nicola (University Hospital of Frankfurt (Alemanya)) ; Dombret, Hervé (Hôpital Saint-Louis, Université Paris Diderot) ; Giebel, Sebastian (Maria Sklodowska Curie Memorial Cancer Center, Gliwice) ; Bruggemann, Monika (Universitätsklinikum Schleswig-Holstein (Alemanya)) ; Doubek, Michael (University Hospital Brno (República Txeca)) ; Foà, Robin (Sapienza University of Rome) ; Hoelzer, Dieter (University Hospital of Frankfurt (Alemanya)) ; Kim, Christopher (Amgen Inc, Thousand Oaks, CA, USA) ; Martinelli, Giovanni (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS) ; Parovichnikova, Elena (National Research Center for Hematology, Moscow) ; Rambaldi, Alessandro (Dipartimento di Oncologia ed Ematologia, Università degli Studi di Milano and Ospedale Papa Giovanni XXIII) ; Ribera, Jose-Maria (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Schoonen, Marieke (Amgen Ltd, London) ; Stieglmaier, Julia M. (Amgen GmBH, Munich) ; Zugmaier, Gerhard (Amgen GmBH, Munich) ; Bassan, Renato (Ospedale dell'Angelo, Mestre-Venezia) ; Universitat Autònoma de Barcelona
Objectives: Detectable minimal residual disease (MRD) after therapy for acute lymphoblastic leukemia (ALL) is the strongest predictor of hematologic relapse. This study evaluated outcomes of patients with B-cell precursor ALL with MRD of ≥10−4. [...]
2019 - 10.1080/16078454.2019.1567654
Hematology, Vol. 24 Núm. 1 (2019) , p. 337-348  
4.
7 p, 444.1 KB Blinatumomab vs historical standard therapy of adult relapsed/refractory acute lymphoblastic leukemia / Gökbuget, N. (Goethe University. University Hospital Frankfurt) ; Kelsh, M. (Amgen (Thousand Oaks, Estats Units d'Amèrica)) ; Chia, V. (Amgen (Thousand Oaks, Estats Units d'Amèrica)) ; Advani, Anjali (Cleveland Clinic (Estats Units d'Amèrica)) ; Bassan, Renato (Ospedale dell'Angelo (Venècia, Itàlia)) ; Dombret, Hervé (Hôpital Saint-Louis (Paris, França)) ; Doubek, Michael (University Hospital Brno (República Txeca)) ; Fielding, A. K. (UCL Cancer Institute (Londres, Regne Unit)) ; Giebel, S. (Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology (Polònia)) ; Haddad, V. (Amgen Ltd. (Uxbridge, Regne Unit)) ; Hoelzer, Dieter (Goethe University. University Hospital Frankfurt) ; Holland, C. (Amgen Ltd. (Rockville, Estats Units d'Amèrica)) ; Ifrah, N. (Centre Hospitalier Universitaire (Angers, França)) ; Katz, A. (Amgen (Thousand Oaks, Estats Units d'Amèrica)) ; Maniar, T. (Amgen (Thousand Oaks, Estats Units d'Amèrica)) ; Martinelli, Giovanni (Policlinico Sant'Orsola-Malpighi (Bolònia, Itàlia)) ; Morgades, Mireia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; O'Brien, Susan (University of Texas MD Anderson Cancer Center (Houston, Texas)) ; Ribera, Jose-Maria (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Rowe, J. M. (Rambam Medical Center) ; Stein, Anthony (City of Hope National Medical Center (Duarte, Estats Units d'Amèrica)) ; Topp, M. (Universitätsklinikum Würzburg (Alemanya)) ; Wadleigh, M. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Kantarjian, H. (University of Texas MD Anderson Cancer Center (Houston, Texas))
We compared outcomes from a single-arm study of blinatumomab in adult patients with B-precursor Ph-negative relapsed/refractory acute lymphoblastic leukemia (R/R ALL) with a historical data set from Europe and the United States. [...]
2016 - 10.1038/bcj.2016.84
Blood Cancer Journal, Vol. 6, Núm. 9 (September 2016) , p. e473  

Vegeu també: autors amb noms similars
1 Giebel, S
3 Giebel, Sebastian
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.